Global Lurasidone Market Insights, Forecast to 2029
This report presents an overview of global market for Lurasidone, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Lurasidone, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Lurasidone, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lurasidone sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Lurasidone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Lurasidone sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Angelini Holding S.p.A., Sumitomo Dainippon Pharma Co., Ltd., RemedyRepack?Inc., Bushu Pharmaceutical, LTD., Zhejiang Hisun Pharmaceutical Co., Ltd., Healthcare Pharmaceuticals Limited, Square Pharmaceuticals Ltd. and Incepta Pharmaceuticals Ltd., etc.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Lurasidone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Lurasidone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lurasidone sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
This report researches the key producers of Lurasidone, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Lurasidone, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Lurasidone sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Lurasidone market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Lurasidone sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Angelini Holding S.p.A., Sumitomo Dainippon Pharma Co., Ltd., RemedyRepack?Inc., Bushu Pharmaceutical, LTD., Zhejiang Hisun Pharmaceutical Co., Ltd., Healthcare Pharmaceuticals Limited, Square Pharmaceuticals Ltd. and Incepta Pharmaceuticals Ltd., etc.
By Company
- Angelini Holding S.p.A.
- Sumitomo Dainippon Pharma Co., Ltd.
- RemedyRepack?Inc.
- Bushu Pharmaceutical, LTD.
- Zhejiang Hisun Pharmaceutical Co., Ltd.
- Healthcare Pharmaceuticals Limited
- Square Pharmaceuticals Ltd.
- Incepta Pharmaceuticals Ltd.
- 20mg/tablet
- 40mg/tablet
- 60mg/tablet
- 80mg/tablet
- 120mg/tablet
- Hospital
- Psychological Clinic
- Others
- US & Canada
- U.S.
- Canada
- China
- Asia (excluding China)
- Japan
- South Korea
- China Taiwan
- Southeast Asia
- India
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Middle East, Africa, Latin America
- Brazil
- Mexico
- Turkey
- Israel
- GCC Countries
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Lurasidone in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Lurasidone manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Lurasidone sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE
1.1 Lurasidone Product Introduction
1.2 Market by Type
1.2.1 Global Lurasidone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 20mg/tablet
1.2.3 40mg/tablet
1.2.4 60mg/tablet
1.2.5 80mg/tablet
1.2.6 120mg/tablet
1.3 Market by Application
1.3.1 Global Lurasidone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Psychological Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Lurasidone Sales Estimates and Forecasts 2018-2029
2.2 Global Lurasidone Revenue by Region
2.2.1 Global Lurasidone Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Lurasidone Revenue by Region (2018-2023)
2.2.3 Global Lurasidone Revenue by Region (2024-2029)
2.2.4 Global Lurasidone Revenue Market Share by Region (2018-2029)
2.3 Global Lurasidone Sales Estimates and Forecasts 2018-2029
2.4 Global Lurasidone Sales by Region
2.4.1 Global Lurasidone Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Lurasidone Sales by Region (2018-2023)
2.4.3 Global Lurasidone Sales by Region (2024-2029)
2.4.4 Global Lurasidone Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Lurasidone Sales by Manufacturers
3.1.1 Global Lurasidone Sales by Manufacturers (2018-2023)
3.1.2 Global Lurasidone Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lurasidone in 2022
3.2 Global Lurasidone Revenue by Manufacturers
3.2.1 Global Lurasidone Revenue by Manufacturers (2018-2023)
3.2.2 Global Lurasidone Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Lurasidone Revenue in 2022
3.3 Global Key Players of Lurasidone, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Lurasidone Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Lurasidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Lurasidone, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Lurasidone, Product Offered and Application
3.8 Global Key Manufacturers of Lurasidone, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Lurasidone Sales by Type
4.1.1 Global Lurasidone Historical Sales by Type (2018-2023)
4.1.2 Global Lurasidone Forecasted Sales by Type (2024-2029)
4.1.3 Global Lurasidone Sales Market Share by Type (2018-2029)
4.2 Global Lurasidone Revenue by Type
4.2.1 Global Lurasidone Historical Revenue by Type (2018-2023)
4.2.2 Global Lurasidone Forecasted Revenue by Type (2024-2029)
4.2.3 Global Lurasidone Revenue Market Share by Type (2018-2029)
4.3 Global Lurasidone Price by Type
4.3.1 Global Lurasidone Price by Type (2018-2023)
4.3.2 Global Lurasidone Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Lurasidone Sales by Application
5.1.1 Global Lurasidone Historical Sales by Application (2018-2023)
5.1.2 Global Lurasidone Forecasted Sales by Application (2024-2029)
5.1.3 Global Lurasidone Sales Market Share by Application (2018-2029)
5.2 Global Lurasidone Revenue by Application
5.2.1 Global Lurasidone Historical Revenue by Application (2018-2023)
5.2.2 Global Lurasidone Forecasted Revenue by Application (2024-2029)
5.2.3 Global Lurasidone Revenue Market Share by Application (2018-2029)
5.3 Global Lurasidone Price by Application
5.3.1 Global Lurasidone Price by Application (2018-2023)
5.3.2 Global Lurasidone Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Lurasidone Market Size by Type
6.1.1 US & Canada Lurasidone Sales by Type (2018-2029)
6.1.2 US & Canada Lurasidone Revenue by Type (2018-2029)
6.2 US & Canada Lurasidone Market Size by Application
6.2.1 US & Canada Lurasidone Sales by Application (2018-2029)
6.2.2 US & Canada Lurasidone Revenue by Application (2018-2029)
6.3 US & Canada Lurasidone Market Size by Country
6.3.1 US & Canada Lurasidone Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Lurasidone Sales by Country (2018-2029)
6.3.3 US & Canada Lurasidone Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Lurasidone Market Size by Type
7.1.1 Europe Lurasidone Sales by Type (2018-2029)
7.1.2 Europe Lurasidone Revenue by Type (2018-2029)
7.2 Europe Lurasidone Market Size by Application
7.2.1 Europe Lurasidone Sales by Application (2018-2029)
7.2.2 Europe Lurasidone Revenue by Application (2018-2029)
7.3 Europe Lurasidone Market Size by Country
7.3.1 Europe Lurasidone Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Lurasidone Sales by Country (2018-2029)
7.3.3 Europe Lurasidone Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Lurasidone Market Size
8.1.1 China Lurasidone Sales (2018-2029)
8.1.2 China Lurasidone Revenue (2018-2029)
8.2 China Lurasidone Market Size by Application
8.2.1 China Lurasidone Sales by Application (2018-2029)
8.2.2 China Lurasidone Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Lurasidone Market Size by Type
9.1.1 Asia Lurasidone Sales by Type (2018-2029)
9.1.2 Asia Lurasidone Revenue by Type (2018-2029)
9.2 Asia Lurasidone Market Size by Application
9.2.1 Asia Lurasidone Sales by Application (2018-2029)
9.2.2 Asia Lurasidone Revenue by Application (2018-2029)
9.3 Asia Lurasidone Sales by Region
9.3.1 Asia Lurasidone Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Lurasidone Revenue by Region (2018-2029)
9.3.3 Asia Lurasidone Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Lurasidone Market Size by Type
10.1.1 Middle East, Africa and Latin America Lurasidone Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Lurasidone Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Lurasidone Market Size by Application
10.2.1 Middle East, Africa and Latin America Lurasidone Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Lurasidone Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Lurasidone Sales by Country
10.3.1 Middle East, Africa and Latin America Lurasidone Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Lurasidone Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Lurasidone Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Angelini Holding S.p.A.
11.1.1 Angelini Holding S.p.A. Company Information
11.1.2 Angelini Holding S.p.A. Overview
11.1.3 Angelini Holding S.p.A. Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Angelini Holding S.p.A. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Angelini Holding S.p.A. Recent Developments
11.2 Sumitomo Dainippon Pharma Co., Ltd.
11.2.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
11.2.2 Sumitomo Dainippon Pharma Co., Ltd. Overview
11.2.3 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
11.3 RemedyRepack?Inc.
11.3.1 RemedyRepack?Inc. Company Information
11.3.2 RemedyRepack?Inc. Overview
11.3.3 RemedyRepack?Inc. Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 RemedyRepack?Inc. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 RemedyRepack?Inc. Recent Developments
11.4 Bushu Pharmaceutical, LTD.
11.4.1 Bushu Pharmaceutical, LTD. Company Information
11.4.2 Bushu Pharmaceutical, LTD. Overview
11.4.3 Bushu Pharmaceutical, LTD. Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Bushu Pharmaceutical, LTD. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bushu Pharmaceutical, LTD. Recent Developments
11.5 Zhejiang Hisun Pharmaceutical Co., Ltd.
11.5.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
11.5.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Overview
11.5.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
11.6 Healthcare Pharmaceuticals Limited
11.6.1 Healthcare Pharmaceuticals Limited Company Information
11.6.2 Healthcare Pharmaceuticals Limited Overview
11.6.3 Healthcare Pharmaceuticals Limited Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Healthcare Pharmaceuticals Limited Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Healthcare Pharmaceuticals Limited Recent Developments
11.7 Square Pharmaceuticals Ltd.
11.7.1 Square Pharmaceuticals Ltd. Company Information
11.7.2 Square Pharmaceuticals Ltd. Overview
11.7.3 Square Pharmaceuticals Ltd. Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Square Pharmaceuticals Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Square Pharmaceuticals Ltd. Recent Developments
11.8 Incepta Pharmaceuticals Ltd.
11.8.1 Incepta Pharmaceuticals Ltd. Company Information
11.8.2 Incepta Pharmaceuticals Ltd. Overview
11.8.3 Incepta Pharmaceuticals Ltd. Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Incepta Pharmaceuticals Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Incepta Pharmaceuticals Ltd. Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Lurasidone Industry Chain Analysis
12.2 Lurasidone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lurasidone Production Mode & Process
12.4 Lurasidone Sales and Marketing
12.4.1 Lurasidone Sales Channels
12.4.2 Lurasidone Distributors
12.5 Lurasidone Customers
13 MARKET DYNAMICS
13.1 Lurasidone Industry Trends
13.2 Lurasidone Market Drivers
13.3 Lurasidone Market Challenges
13.4 Lurasidone Market Restraints
14 KEY FINDINGS IN THE GLOBAL LURASIDONE STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
1.1 Lurasidone Product Introduction
1.2 Market by Type
1.2.1 Global Lurasidone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 20mg/tablet
1.2.3 40mg/tablet
1.2.4 60mg/tablet
1.2.5 80mg/tablet
1.2.6 120mg/tablet
1.3 Market by Application
1.3.1 Global Lurasidone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Psychological Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global Lurasidone Sales Estimates and Forecasts 2018-2029
2.2 Global Lurasidone Revenue by Region
2.2.1 Global Lurasidone Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Lurasidone Revenue by Region (2018-2023)
2.2.3 Global Lurasidone Revenue by Region (2024-2029)
2.2.4 Global Lurasidone Revenue Market Share by Region (2018-2029)
2.3 Global Lurasidone Sales Estimates and Forecasts 2018-2029
2.4 Global Lurasidone Sales by Region
2.4.1 Global Lurasidone Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Lurasidone Sales by Region (2018-2023)
2.4.3 Global Lurasidone Sales by Region (2024-2029)
2.4.4 Global Lurasidone Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 COMPETITION BY MANUFACTURES
3.1 Global Lurasidone Sales by Manufacturers
3.1.1 Global Lurasidone Sales by Manufacturers (2018-2023)
3.1.2 Global Lurasidone Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Lurasidone in 2022
3.2 Global Lurasidone Revenue by Manufacturers
3.2.1 Global Lurasidone Revenue by Manufacturers (2018-2023)
3.2.2 Global Lurasidone Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Lurasidone Revenue in 2022
3.3 Global Key Players of Lurasidone, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Lurasidone Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Lurasidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Lurasidone, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Lurasidone, Product Offered and Application
3.8 Global Key Manufacturers of Lurasidone, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 MARKET SIZE BY TYPE
4.1 Global Lurasidone Sales by Type
4.1.1 Global Lurasidone Historical Sales by Type (2018-2023)
4.1.2 Global Lurasidone Forecasted Sales by Type (2024-2029)
4.1.3 Global Lurasidone Sales Market Share by Type (2018-2029)
4.2 Global Lurasidone Revenue by Type
4.2.1 Global Lurasidone Historical Revenue by Type (2018-2023)
4.2.2 Global Lurasidone Forecasted Revenue by Type (2024-2029)
4.2.3 Global Lurasidone Revenue Market Share by Type (2018-2029)
4.3 Global Lurasidone Price by Type
4.3.1 Global Lurasidone Price by Type (2018-2023)
4.3.2 Global Lurasidone Price Forecast by Type (2024-2029)
5 MARKET SIZE BY APPLICATION
5.1 Global Lurasidone Sales by Application
5.1.1 Global Lurasidone Historical Sales by Application (2018-2023)
5.1.2 Global Lurasidone Forecasted Sales by Application (2024-2029)
5.1.3 Global Lurasidone Sales Market Share by Application (2018-2029)
5.2 Global Lurasidone Revenue by Application
5.2.1 Global Lurasidone Historical Revenue by Application (2018-2023)
5.2.2 Global Lurasidone Forecasted Revenue by Application (2024-2029)
5.2.3 Global Lurasidone Revenue Market Share by Application (2018-2029)
5.3 Global Lurasidone Price by Application
5.3.1 Global Lurasidone Price by Application (2018-2023)
5.3.2 Global Lurasidone Price Forecast by Application (2024-2029)
6 US & CANADA
6.1 US & Canada Lurasidone Market Size by Type
6.1.1 US & Canada Lurasidone Sales by Type (2018-2029)
6.1.2 US & Canada Lurasidone Revenue by Type (2018-2029)
6.2 US & Canada Lurasidone Market Size by Application
6.2.1 US & Canada Lurasidone Sales by Application (2018-2029)
6.2.2 US & Canada Lurasidone Revenue by Application (2018-2029)
6.3 US & Canada Lurasidone Market Size by Country
6.3.1 US & Canada Lurasidone Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Lurasidone Sales by Country (2018-2029)
6.3.3 US & Canada Lurasidone Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 EUROPE
7.1 Europe Lurasidone Market Size by Type
7.1.1 Europe Lurasidone Sales by Type (2018-2029)
7.1.2 Europe Lurasidone Revenue by Type (2018-2029)
7.2 Europe Lurasidone Market Size by Application
7.2.1 Europe Lurasidone Sales by Application (2018-2029)
7.2.2 Europe Lurasidone Revenue by Application (2018-2029)
7.3 Europe Lurasidone Market Size by Country
7.3.1 Europe Lurasidone Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Lurasidone Sales by Country (2018-2029)
7.3.3 Europe Lurasidone Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 CHINA
8.1 China Lurasidone Market Size
8.1.1 China Lurasidone Sales (2018-2029)
8.1.2 China Lurasidone Revenue (2018-2029)
8.2 China Lurasidone Market Size by Application
8.2.1 China Lurasidone Sales by Application (2018-2029)
8.2.2 China Lurasidone Revenue by Application (2018-2029)
9 ASIA (EXCLUDING CHINA)
9.1 Asia Lurasidone Market Size by Type
9.1.1 Asia Lurasidone Sales by Type (2018-2029)
9.1.2 Asia Lurasidone Revenue by Type (2018-2029)
9.2 Asia Lurasidone Market Size by Application
9.2.1 Asia Lurasidone Sales by Application (2018-2029)
9.2.2 Asia Lurasidone Revenue by Application (2018-2029)
9.3 Asia Lurasidone Sales by Region
9.3.1 Asia Lurasidone Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Lurasidone Revenue by Region (2018-2029)
9.3.3 Asia Lurasidone Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 MIDDLE EAST, AFRICA AND LATIN AMERICA
10.1 Middle East, Africa and Latin America Lurasidone Market Size by Type
10.1.1 Middle East, Africa and Latin America Lurasidone Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Lurasidone Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Lurasidone Market Size by Application
10.2.1 Middle East, Africa and Latin America Lurasidone Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Lurasidone Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Lurasidone Sales by Country
10.3.1 Middle East, Africa and Latin America Lurasidone Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Lurasidone Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Lurasidone Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 COMPANY PROFILES
11.1 Angelini Holding S.p.A.
11.1.1 Angelini Holding S.p.A. Company Information
11.1.2 Angelini Holding S.p.A. Overview
11.1.3 Angelini Holding S.p.A. Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Angelini Holding S.p.A. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Angelini Holding S.p.A. Recent Developments
11.2 Sumitomo Dainippon Pharma Co., Ltd.
11.2.1 Sumitomo Dainippon Pharma Co., Ltd. Company Information
11.2.2 Sumitomo Dainippon Pharma Co., Ltd. Overview
11.2.3 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
11.3 RemedyRepack?Inc.
11.3.1 RemedyRepack?Inc. Company Information
11.3.2 RemedyRepack?Inc. Overview
11.3.3 RemedyRepack?Inc. Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 RemedyRepack?Inc. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 RemedyRepack?Inc. Recent Developments
11.4 Bushu Pharmaceutical, LTD.
11.4.1 Bushu Pharmaceutical, LTD. Company Information
11.4.2 Bushu Pharmaceutical, LTD. Overview
11.4.3 Bushu Pharmaceutical, LTD. Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Bushu Pharmaceutical, LTD. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bushu Pharmaceutical, LTD. Recent Developments
11.5 Zhejiang Hisun Pharmaceutical Co., Ltd.
11.5.1 Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
11.5.2 Zhejiang Hisun Pharmaceutical Co., Ltd. Overview
11.5.3 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
11.6 Healthcare Pharmaceuticals Limited
11.6.1 Healthcare Pharmaceuticals Limited Company Information
11.6.2 Healthcare Pharmaceuticals Limited Overview
11.6.3 Healthcare Pharmaceuticals Limited Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Healthcare Pharmaceuticals Limited Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Healthcare Pharmaceuticals Limited Recent Developments
11.7 Square Pharmaceuticals Ltd.
11.7.1 Square Pharmaceuticals Ltd. Company Information
11.7.2 Square Pharmaceuticals Ltd. Overview
11.7.3 Square Pharmaceuticals Ltd. Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Square Pharmaceuticals Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Square Pharmaceuticals Ltd. Recent Developments
11.8 Incepta Pharmaceuticals Ltd.
11.8.1 Incepta Pharmaceuticals Ltd. Company Information
11.8.2 Incepta Pharmaceuticals Ltd. Overview
11.8.3 Incepta Pharmaceuticals Ltd. Lurasidone Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Incepta Pharmaceuticals Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Incepta Pharmaceuticals Ltd. Recent Developments
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
12.1 Lurasidone Industry Chain Analysis
12.2 Lurasidone Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Lurasidone Production Mode & Process
12.4 Lurasidone Sales and Marketing
12.4.1 Lurasidone Sales Channels
12.4.2 Lurasidone Distributors
12.5 Lurasidone Customers
13 MARKET DYNAMICS
13.1 Lurasidone Industry Trends
13.2 Lurasidone Market Drivers
13.3 Lurasidone Market Challenges
13.4 Lurasidone Market Restraints
14 KEY FINDINGS IN THE GLOBAL LURASIDONE STUDY
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
LIST OF TABLES
Table 1. Global Lurasidone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 20mg/tablet
Table 3. Major Manufacturers of 40mg/tablet
Table 4. Major Manufacturers of 60mg/tablet
Table 5. Major Manufacturers of 80mg/tablet
Table 6. Major Manufacturers of 120mg/tablet
Table 7. Global Lurasidone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Lurasidone Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Lurasidone Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Lurasidone Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Lurasidone Revenue Market Share by Region (2018-2023)
Table 12. Global Lurasidone Revenue Market Share by Region (2024-2029)
Table 13. Global Lurasidone Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Lurasidone Sales by Region (2018-2023) & (K Units)
Table 15. Global Lurasidone Sales by Region (2024-2029) & (K Units)
Table 16. Global Lurasidone Sales Market Share by Region (2018-2023)
Table 17. Global Lurasidone Sales Market Share by Region (2024-2029)
Table 18. Global Lurasidone Sales by Manufacturers (2018-2023) & (K Units)
Table 19. Global Lurasidone Sales Share by Manufacturers (2018-2023)
Table 20. Global Lurasidone Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Lurasidone Revenue Share by Manufacturers (2018-2023)
Table 22. Global Key Players of Lurasidone, Industry Ranking, 2021 VS 2022 VS 2023
Table 23. Lurasidone Price by Manufacturers 2018-2023 (US$/Unit)
Table 24. Global Lurasidone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Lurasidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lurasidone as of 2022)
Table 26. Global Key Manufacturers of Lurasidone, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Lurasidone, Product Offered and Application
Table 28. Global Key Manufacturers of Lurasidone, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Lurasidone Sales by Type (2018-2023) & (K Units)
Table 31. Global Lurasidone Sales by Type (2024-2029) & (K Units)
Table 32. Global Lurasidone Sales Share by Type (2018-2023)
Table 33. Global Lurasidone Sales Share by Type (2024-2029)
Table 34. Global Lurasidone Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Lurasidone Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Lurasidone Revenue Share by Type (2018-2023)
Table 37. Global Lurasidone Revenue Share by Type (2024-2029)
Table 38. Lurasidone Price by Type (2018-2023) & (US$/Unit)
Table 39. Global Lurasidone Price Forecast by Type (2024-2029) & (US$/Unit)
Table 40. Global Lurasidone Sales by Application (2018-2023) & (K Units)
Table 41. Global Lurasidone Sales by Application (2024-2029) & (K Units)
Table 42. Global Lurasidone Sales Share by Application (2018-2023)
Table 43. Global Lurasidone Sales Share by Application (2024-2029)
Table 44. Global Lurasidone Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Lurasidone Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Lurasidone Revenue Share by Application (2018-2023)
Table 47. Global Lurasidone Revenue Share by Application (2024-2029)
Table 48. Lurasidone Price by Application (2018-2023) & (US$/Unit)
Table 49. Global Lurasidone Price Forecast by Application (2024-2029) & (US$/Unit)
Table 50. US & Canada Lurasidone Sales by Type (2018-2023) & (K Units)
Table 51. US & Canada Lurasidone Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Lurasidone Revenue by Type (2018-2023) & (US$ Million)
Table 53. US & Canada Lurasidone Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Lurasidone Sales by Application (2018-2023) & (K Units)
Table 55. US & Canada Lurasidone Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Lurasidone Revenue by Application (2018-2023) & (US$ Million)
Table 57. US & Canada Lurasidone Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Lurasidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Lurasidone Revenue by Country (2018-2023) & (US$ Million)
Table 60. US & Canada Lurasidone Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Lurasidone Sales by Country (2018-2023) & (K Units)
Table 62. US & Canada Lurasidone Sales by Country (2024-2029) & (K Units)
Table 63. Europe Lurasidone Sales by Type (2018-2023) & (K Units)
Table 64. Europe Lurasidone Sales by Type (2024-2029) & (K Units)
Table 65. Europe Lurasidone Revenue by Type (2018-2023) & (US$ Million)
Table 66. Europe Lurasidone Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Lurasidone Sales by Application (2018-2023) & (K Units)
Table 68. Europe Lurasidone Sales by Application (2024-2029) & (K Units)
Table 69. Europe Lurasidone Revenue by Application (2018-2023) & (US$ Million)
Table 70. Europe Lurasidone Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Lurasidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Lurasidone Revenue by Country (2018-2023) & (US$ Million)
Table 73. Europe Lurasidone Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Lurasidone Sales by Country (2018-2023) & (K Units)
Table 75. Europe Lurasidone Sales by Country (2024-2029) & (K Units)
Table 76. China Lurasidone Sales by Type (2018-2023) & (K Units)
Table 77. China Lurasidone Sales by Type (2024-2029) & (K Units)
Table 78. China Lurasidone Revenue by Type (2018-2023) & (US$ Million)
Table 79. China Lurasidone Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Lurasidone Sales by Application (2018-2023) & (K Units)
Table 81. China Lurasidone Sales by Application (2024-2029) & (K Units)
Table 82. China Lurasidone Revenue by Application (2018-2023) & (US$ Million)
Table 83. China Lurasidone Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Lurasidone Sales by Type (2018-2023) & (K Units)
Table 85. Asia Lurasidone Sales by Type (2024-2029) & (K Units)
Table 86. Asia Lurasidone Revenue by Type (2018-2023) & (US$ Million)
Table 87. Asia Lurasidone Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Lurasidone Sales by Application (2018-2023) & (K Units)
Table 89. Asia Lurasidone Sales by Application (2024-2029) & (K Units)
Table 90. Asia Lurasidone Revenue by Application (2018-2023) & (US$ Million)
Table 91. Asia Lurasidone Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Lurasidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Lurasidone Revenue by Region (2018-2023) & (US$ Million)
Table 94. Asia Lurasidone Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Lurasidone Sales by Region (2018-2023) & (K Units)
Table 96. Asia Lurasidone Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Lurasidone Sales by Type (2018-2023) & (K Units)
Table 98. Middle East, Africa and Latin America Lurasidone Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Lurasidone Revenue by Type (2018-2023) & (US$ Million)
Table 100. Middle East, Africa and Latin America Lurasidone Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Lurasidone Sales by Application (2018-2023) & (K Units)
Table 102. Middle East, Africa and Latin America Lurasidone Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Lurasidone Revenue by Application (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Lurasidone Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Lurasidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Lurasidone Revenue by Country (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Lurasidone Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Lurasidone Sales by Country (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Lurasidone Sales by Country (2024-2029) & (K Units)
Table 110. Angelini Holding S.p.A. Company Information
Table 111. Angelini Holding S.p.A. Description and Major Businesses
Table 112. Angelini Holding S.p.A. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Angelini Holding S.p.A. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Angelini Holding S.p.A. Recent Developments
Table 115. Sumitomo Dainippon Pharma Co., Ltd. Company Information
Table 116. Sumitomo Dainippon Pharma Co., Ltd. Description and Major Businesses
Table 117. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
Table 120. RemedyRepack?Inc. Company Information
Table 121. RemedyRepack?Inc. Description and Major Businesses
Table 122. RemedyRepack?Inc. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. RemedyRepack?Inc. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. RemedyRepack?Inc. Recent Developments
Table 125. Bushu Pharmaceutical, LTD. Company Information
Table 126. Bushu Pharmaceutical, LTD. Description and Major Businesses
Table 127. Bushu Pharmaceutical, LTD. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Bushu Pharmaceutical, LTD. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Bushu Pharmaceutical, LTD. Recent Developments
Table 130. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
Table 131. Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Major Businesses
Table 132. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
Table 135. Healthcare Pharmaceuticals Limited Company Information
Table 136. Healthcare Pharmaceuticals Limited Description and Major Businesses
Table 137. Healthcare Pharmaceuticals Limited Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Healthcare Pharmaceuticals Limited Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Healthcare Pharmaceuticals Limited Recent Developments
Table 140. Square Pharmaceuticals Ltd. Company Information
Table 141. Square Pharmaceuticals Ltd. Description and Major Businesses
Table 142. Square Pharmaceuticals Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Square Pharmaceuticals Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Square Pharmaceuticals Ltd. Recent Developments
Table 145. Incepta Pharmaceuticals Ltd. Company Information
Table 146. Incepta Pharmaceuticals Ltd. Description and Major Businesses
Table 147. Incepta Pharmaceuticals Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Incepta Pharmaceuticals Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Incepta Pharmaceuticals Ltd. Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Lurasidone Distributors List
Table 153. Lurasidone Customers List
Table 154. Lurasidone Market Trends
Table 155. Lurasidone Market Drivers
Table 156. Lurasidone Market Challenges
Table 157. Lurasidone Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
Table 1. Global Lurasidone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of 20mg/tablet
Table 3. Major Manufacturers of 40mg/tablet
Table 4. Major Manufacturers of 60mg/tablet
Table 5. Major Manufacturers of 80mg/tablet
Table 6. Major Manufacturers of 120mg/tablet
Table 7. Global Lurasidone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Lurasidone Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Lurasidone Revenue by Region (2018-2023) & (US$ Million)
Table 10. Global Lurasidone Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Lurasidone Revenue Market Share by Region (2018-2023)
Table 12. Global Lurasidone Revenue Market Share by Region (2024-2029)
Table 13. Global Lurasidone Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Lurasidone Sales by Region (2018-2023) & (K Units)
Table 15. Global Lurasidone Sales by Region (2024-2029) & (K Units)
Table 16. Global Lurasidone Sales Market Share by Region (2018-2023)
Table 17. Global Lurasidone Sales Market Share by Region (2024-2029)
Table 18. Global Lurasidone Sales by Manufacturers (2018-2023) & (K Units)
Table 19. Global Lurasidone Sales Share by Manufacturers (2018-2023)
Table 20. Global Lurasidone Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 21. Global Lurasidone Revenue Share by Manufacturers (2018-2023)
Table 22. Global Key Players of Lurasidone, Industry Ranking, 2021 VS 2022 VS 2023
Table 23. Lurasidone Price by Manufacturers 2018-2023 (US$/Unit)
Table 24. Global Lurasidone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Lurasidone by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lurasidone as of 2022)
Table 26. Global Key Manufacturers of Lurasidone, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Lurasidone, Product Offered and Application
Table 28. Global Key Manufacturers of Lurasidone, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Lurasidone Sales by Type (2018-2023) & (K Units)
Table 31. Global Lurasidone Sales by Type (2024-2029) & (K Units)
Table 32. Global Lurasidone Sales Share by Type (2018-2023)
Table 33. Global Lurasidone Sales Share by Type (2024-2029)
Table 34. Global Lurasidone Revenue by Type (2018-2023) & (US$ Million)
Table 35. Global Lurasidone Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Lurasidone Revenue Share by Type (2018-2023)
Table 37. Global Lurasidone Revenue Share by Type (2024-2029)
Table 38. Lurasidone Price by Type (2018-2023) & (US$/Unit)
Table 39. Global Lurasidone Price Forecast by Type (2024-2029) & (US$/Unit)
Table 40. Global Lurasidone Sales by Application (2018-2023) & (K Units)
Table 41. Global Lurasidone Sales by Application (2024-2029) & (K Units)
Table 42. Global Lurasidone Sales Share by Application (2018-2023)
Table 43. Global Lurasidone Sales Share by Application (2024-2029)
Table 44. Global Lurasidone Revenue by Application (2018-2023) & (US$ Million)
Table 45. Global Lurasidone Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Lurasidone Revenue Share by Application (2018-2023)
Table 47. Global Lurasidone Revenue Share by Application (2024-2029)
Table 48. Lurasidone Price by Application (2018-2023) & (US$/Unit)
Table 49. Global Lurasidone Price Forecast by Application (2024-2029) & (US$/Unit)
Table 50. US & Canada Lurasidone Sales by Type (2018-2023) & (K Units)
Table 51. US & Canada Lurasidone Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Lurasidone Revenue by Type (2018-2023) & (US$ Million)
Table 53. US & Canada Lurasidone Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Lurasidone Sales by Application (2018-2023) & (K Units)
Table 55. US & Canada Lurasidone Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Lurasidone Revenue by Application (2018-2023) & (US$ Million)
Table 57. US & Canada Lurasidone Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Lurasidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Lurasidone Revenue by Country (2018-2023) & (US$ Million)
Table 60. US & Canada Lurasidone Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Lurasidone Sales by Country (2018-2023) & (K Units)
Table 62. US & Canada Lurasidone Sales by Country (2024-2029) & (K Units)
Table 63. Europe Lurasidone Sales by Type (2018-2023) & (K Units)
Table 64. Europe Lurasidone Sales by Type (2024-2029) & (K Units)
Table 65. Europe Lurasidone Revenue by Type (2018-2023) & (US$ Million)
Table 66. Europe Lurasidone Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Lurasidone Sales by Application (2018-2023) & (K Units)
Table 68. Europe Lurasidone Sales by Application (2024-2029) & (K Units)
Table 69. Europe Lurasidone Revenue by Application (2018-2023) & (US$ Million)
Table 70. Europe Lurasidone Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Lurasidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Lurasidone Revenue by Country (2018-2023) & (US$ Million)
Table 73. Europe Lurasidone Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Lurasidone Sales by Country (2018-2023) & (K Units)
Table 75. Europe Lurasidone Sales by Country (2024-2029) & (K Units)
Table 76. China Lurasidone Sales by Type (2018-2023) & (K Units)
Table 77. China Lurasidone Sales by Type (2024-2029) & (K Units)
Table 78. China Lurasidone Revenue by Type (2018-2023) & (US$ Million)
Table 79. China Lurasidone Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Lurasidone Sales by Application (2018-2023) & (K Units)
Table 81. China Lurasidone Sales by Application (2024-2029) & (K Units)
Table 82. China Lurasidone Revenue by Application (2018-2023) & (US$ Million)
Table 83. China Lurasidone Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Lurasidone Sales by Type (2018-2023) & (K Units)
Table 85. Asia Lurasidone Sales by Type (2024-2029) & (K Units)
Table 86. Asia Lurasidone Revenue by Type (2018-2023) & (US$ Million)
Table 87. Asia Lurasidone Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Lurasidone Sales by Application (2018-2023) & (K Units)
Table 89. Asia Lurasidone Sales by Application (2024-2029) & (K Units)
Table 90. Asia Lurasidone Revenue by Application (2018-2023) & (US$ Million)
Table 91. Asia Lurasidone Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Lurasidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Lurasidone Revenue by Region (2018-2023) & (US$ Million)
Table 94. Asia Lurasidone Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Lurasidone Sales by Region (2018-2023) & (K Units)
Table 96. Asia Lurasidone Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Lurasidone Sales by Type (2018-2023) & (K Units)
Table 98. Middle East, Africa and Latin America Lurasidone Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Lurasidone Revenue by Type (2018-2023) & (US$ Million)
Table 100. Middle East, Africa and Latin America Lurasidone Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Lurasidone Sales by Application (2018-2023) & (K Units)
Table 102. Middle East, Africa and Latin America Lurasidone Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Lurasidone Revenue by Application (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Lurasidone Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Lurasidone Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Lurasidone Revenue by Country (2018-2023) & (US$ Million)
Table 107. Middle East, Africa and Latin America Lurasidone Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Lurasidone Sales by Country (2018-2023) & (K Units)
Table 109. Middle East, Africa and Latin America Lurasidone Sales by Country (2024-2029) & (K Units)
Table 110. Angelini Holding S.p.A. Company Information
Table 111. Angelini Holding S.p.A. Description and Major Businesses
Table 112. Angelini Holding S.p.A. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Angelini Holding S.p.A. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Angelini Holding S.p.A. Recent Developments
Table 115. Sumitomo Dainippon Pharma Co., Ltd. Company Information
Table 116. Sumitomo Dainippon Pharma Co., Ltd. Description and Major Businesses
Table 117. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Sumitomo Dainippon Pharma Co., Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Sumitomo Dainippon Pharma Co., Ltd. Recent Developments
Table 120. RemedyRepack?Inc. Company Information
Table 121. RemedyRepack?Inc. Description and Major Businesses
Table 122. RemedyRepack?Inc. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. RemedyRepack?Inc. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. RemedyRepack?Inc. Recent Developments
Table 125. Bushu Pharmaceutical, LTD. Company Information
Table 126. Bushu Pharmaceutical, LTD. Description and Major Businesses
Table 127. Bushu Pharmaceutical, LTD. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Bushu Pharmaceutical, LTD. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Bushu Pharmaceutical, LTD. Recent Developments
Table 130. Zhejiang Hisun Pharmaceutical Co., Ltd. Company Information
Table 131. Zhejiang Hisun Pharmaceutical Co., Ltd. Description and Major Businesses
Table 132. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Zhejiang Hisun Pharmaceutical Co., Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Zhejiang Hisun Pharmaceutical Co., Ltd. Recent Developments
Table 135. Healthcare Pharmaceuticals Limited Company Information
Table 136. Healthcare Pharmaceuticals Limited Description and Major Businesses
Table 137. Healthcare Pharmaceuticals Limited Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. Healthcare Pharmaceuticals Limited Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Healthcare Pharmaceuticals Limited Recent Developments
Table 140. Square Pharmaceuticals Ltd. Company Information
Table 141. Square Pharmaceuticals Ltd. Description and Major Businesses
Table 142. Square Pharmaceuticals Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 143. Square Pharmaceuticals Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Square Pharmaceuticals Ltd. Recent Developments
Table 145. Incepta Pharmaceuticals Ltd. Company Information
Table 146. Incepta Pharmaceuticals Ltd. Description and Major Businesses
Table 147. Incepta Pharmaceuticals Ltd. Lurasidone Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 148. Incepta Pharmaceuticals Ltd. Lurasidone Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Incepta Pharmaceuticals Ltd. Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Lurasidone Distributors List
Table 153. Lurasidone Customers List
Table 154. Lurasidone Market Trends
Table 155. Lurasidone Market Drivers
Table 156. Lurasidone Market Challenges
Table 157. Lurasidone Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Lurasidone Product Picture
Figure 2. Global Lurasidone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Lurasidone Market Share by Type in 2022 & 2029
Figure 4. 20mg/tablet Product Picture
Figure 5. 40mg/tablet Product Picture
Figure 6. 60mg/tablet Product Picture
Figure 7. 80mg/tablet Product Picture
Figure 8. 120mg/tablet Product Picture
Figure 9. Global Lurasidone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Lurasidone Market Share by Application in 2022 & 2029
Figure 11. Hospital
Figure 12. Psychological Clinic
Figure 13. Others
Figure 14. Lurasidone Report Years Considered
Figure 15. Global Lurasidone Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Lurasidone Revenue 2018-2029 (US$ Million)
Figure 17. Global Lurasidone Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Lurasidone Revenue Market Share by Region (2018-2029)
Figure 19. Global Lurasidone Sales 2018-2029 ((K Units)
Figure 20. Global Lurasidone Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Lurasidone Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Lurasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Lurasidone Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Lurasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Lurasidone Sales YoY (2018-2029) & (K Units)
Figure 26. China Lurasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Lurasidone Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) Lurasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Lurasidone Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America Lurasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Lurasidone Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Lurasidone in the World: Market Share by Lurasidone Revenue in 2022
Figure 33. Global Lurasidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Lurasidone Sales Market Share by Type (2018-2029)
Figure 35. Global Lurasidone Revenue Market Share by Type (2018-2029)
Figure 36. Global Lurasidone Sales Market Share by Application (2018-2029)
Figure 37. Global Lurasidone Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Lurasidone Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Lurasidone Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Lurasidone Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Lurasidone Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Lurasidone Revenue Share by Country (2018-2029)
Figure 43. US & Canada Lurasidone Sales Share by Country (2018-2029)
Figure 44. U.S. Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Lurasidone Sales Market Share by Type (2018-2029)
Figure 47. Europe Lurasidone Revenue Market Share by Type (2018-2029)
Figure 48. Europe Lurasidone Sales Market Share by Application (2018-2029)
Figure 49. Europe Lurasidone Revenue Market Share by Application (2018-2029)
Figure 50. Europe Lurasidone Revenue Share by Country (2018-2029)
Figure 51. Europe Lurasidone Sales Share by Country (2018-2029)
Figure 52. Germany Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 53. France Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 57. China Lurasidone Sales Market Share by Type (2018-2029)
Figure 58. China Lurasidone Revenue Market Share by Type (2018-2029)
Figure 59. China Lurasidone Sales Market Share by Application (2018-2029)
Figure 60. China Lurasidone Revenue Market Share by Application (2018-2029)
Figure 61. Asia Lurasidone Sales Market Share by Type (2018-2029)
Figure 62. Asia Lurasidone Revenue Market Share by Type (2018-2029)
Figure 63. Asia Lurasidone Sales Market Share by Application (2018-2029)
Figure 64. Asia Lurasidone Revenue Market Share by Application (2018-2029)
Figure 65. Asia Lurasidone Revenue Share by Region (2018-2029)
Figure 66. Asia Lurasidone Sales Share by Region (2018-2029)
Figure 67. Japan Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 71. India Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Lurasidone Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Lurasidone Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Lurasidone Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Lurasidone Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Lurasidone Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Lurasidone Sales Share by Country (2018-2029)
Figure 78. Brazil Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 83. Lurasidone Value Chain
Figure 84. Lurasidone Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
Figure 1. Lurasidone Product Picture
Figure 2. Global Lurasidone Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Lurasidone Market Share by Type in 2022 & 2029
Figure 4. 20mg/tablet Product Picture
Figure 5. 40mg/tablet Product Picture
Figure 6. 60mg/tablet Product Picture
Figure 7. 80mg/tablet Product Picture
Figure 8. 120mg/tablet Product Picture
Figure 9. Global Lurasidone Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Lurasidone Market Share by Application in 2022 & 2029
Figure 11. Hospital
Figure 12. Psychological Clinic
Figure 13. Others
Figure 14. Lurasidone Report Years Considered
Figure 15. Global Lurasidone Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 16. Global Lurasidone Revenue 2018-2029 (US$ Million)
Figure 17. Global Lurasidone Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 18. Global Lurasidone Revenue Market Share by Region (2018-2029)
Figure 19. Global Lurasidone Sales 2018-2029 ((K Units)
Figure 20. Global Lurasidone Sales Market Share by Region (2018-2029)
Figure 21. US & Canada Lurasidone Sales YoY (2018-2029) & (K Units)
Figure 22. US & Canada Lurasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Europe Lurasidone Sales YoY (2018-2029) & (K Units)
Figure 24. Europe Lurasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 25. China Lurasidone Sales YoY (2018-2029) & (K Units)
Figure 26. China Lurasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Asia (excluding China) Lurasidone Sales YoY (2018-2029) & (K Units)
Figure 28. Asia (excluding China) Lurasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 29. Middle East, Africa and Latin America Lurasidone Sales YoY (2018-2029) & (K Units)
Figure 30. Middle East, Africa and Latin America Lurasidone Revenue YoY (2018-2029) & (US$ Million)
Figure 31. The Lurasidone Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 32. The Top 5 and 10 Largest Manufacturers of Lurasidone in the World: Market Share by Lurasidone Revenue in 2022
Figure 33. Global Lurasidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 34. Global Lurasidone Sales Market Share by Type (2018-2029)
Figure 35. Global Lurasidone Revenue Market Share by Type (2018-2029)
Figure 36. Global Lurasidone Sales Market Share by Application (2018-2029)
Figure 37. Global Lurasidone Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Lurasidone Sales Market Share by Type (2018-2029)
Figure 39. US & Canada Lurasidone Revenue Market Share by Type (2018-2029)
Figure 40. US & Canada Lurasidone Sales Market Share by Application (2018-2029)
Figure 41. US & Canada Lurasidone Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Lurasidone Revenue Share by Country (2018-2029)
Figure 43. US & Canada Lurasidone Sales Share by Country (2018-2029)
Figure 44. U.S. Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 45. Canada Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 46. Europe Lurasidone Sales Market Share by Type (2018-2029)
Figure 47. Europe Lurasidone Revenue Market Share by Type (2018-2029)
Figure 48. Europe Lurasidone Sales Market Share by Application (2018-2029)
Figure 49. Europe Lurasidone Revenue Market Share by Application (2018-2029)
Figure 50. Europe Lurasidone Revenue Share by Country (2018-2029)
Figure 51. Europe Lurasidone Sales Share by Country (2018-2029)
Figure 52. Germany Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 53. France Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 54. U.K. Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 55. Italy Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 56. Russia Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 57. China Lurasidone Sales Market Share by Type (2018-2029)
Figure 58. China Lurasidone Revenue Market Share by Type (2018-2029)
Figure 59. China Lurasidone Sales Market Share by Application (2018-2029)
Figure 60. China Lurasidone Revenue Market Share by Application (2018-2029)
Figure 61. Asia Lurasidone Sales Market Share by Type (2018-2029)
Figure 62. Asia Lurasidone Revenue Market Share by Type (2018-2029)
Figure 63. Asia Lurasidone Sales Market Share by Application (2018-2029)
Figure 64. Asia Lurasidone Revenue Market Share by Application (2018-2029)
Figure 65. Asia Lurasidone Revenue Share by Region (2018-2029)
Figure 66. Asia Lurasidone Sales Share by Region (2018-2029)
Figure 67. Japan Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 68. South Korea Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 69. China Taiwan Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 70. Southeast Asia Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 71. India Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 72. Middle East, Africa and Latin America Lurasidone Sales Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Lurasidone Revenue Market Share by Type (2018-2029)
Figure 74. Middle East, Africa and Latin America Lurasidone Sales Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Lurasidone Revenue Market Share by Application (2018-2029)
Figure 76. Middle East, Africa and Latin America Lurasidone Revenue Share by Country (2018-2029)
Figure 77. Middle East, Africa and Latin America Lurasidone Sales Share by Country (2018-2029)
Figure 78. Brazil Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 79. Mexico Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 80. Turkey Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 81. Israel Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 82. GCC Countries Lurasidone Revenue (2018-2029) & (US$ Million)
Figure 83. Lurasidone Value Chain
Figure 84. Lurasidone Production Process
Figure 85. Channels of Distribution
Figure 86. Distributors Profiles
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
